Background The lung allocation score (LAS) was introduced in the United States in May 2005 with the main goal of reducing the waiting list mortality of patients with end-stage lung diseases, but also to enhance the lung transplant benefit and improve the management of urgent candidates. Several papers have reported that LAS resulted in a reduction of the waiting list mortality but no significant survival benefit was noted. Methods We evaluate the usefulness of LAS as a predictor for lung transplantation outcome in 123 patients listed for lung transplantation in an Italian center. Primary endpoints were waiting list mortality and posttransplant mortality at 1 year; secondary endpoints included perioperative circulatory support, cardiopulmonary bypass, primary graft dysfunction, and long-term survival after transplantation. Results We observed the absence of correlation between LAS and waiting list mortality. The LAS did not affect the long-term survival in our population. Conclusions High LAS was predictive of primary graft dysfunction of grade 3 in the first 72 hours after transplantation.
|Number of pages||4|
|Publication status||Published - Mar 1 2016|
ASJC Scopus subject areas